Cargando…
HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique
BACKGROUND: Few data on HIV resistance in pregnancy are available from Mozambique, one of the countries with the highest HIV toll worldwide. Understanding the patterns of HIV drug resistance in pregnant women might help in tailoring optimal regimens for prevention of mother to child transmission of...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942837/ https://www.ncbi.nlm.nih.gov/pubmed/29742132 http://dx.doi.org/10.1371/journal.pone.0196451 |
_version_ | 1783321528192991232 |
---|---|
author | Rupérez, María Noguera-Julian, Marc González, Raquel Maculuve, Sonia Bellido, Rocío Vala, Anifa Rodríguez, Cristina Sevene, Esperança Paredes, Roger Menéndez, Clara |
author_facet | Rupérez, María Noguera-Julian, Marc González, Raquel Maculuve, Sonia Bellido, Rocío Vala, Anifa Rodríguez, Cristina Sevene, Esperança Paredes, Roger Menéndez, Clara |
author_sort | Rupérez, María |
collection | PubMed |
description | BACKGROUND: Few data on HIV resistance in pregnancy are available from Mozambique, one of the countries with the highest HIV toll worldwide. Understanding the patterns of HIV drug resistance in pregnant women might help in tailoring optimal regimens for prevention of mother to child transmission of HIV (pMTCT) and antenatal care. OBJECTIVES: To describe the frequency and characteristics of HIV drug resistance mutations (HIVDRM) in pregnant women with virological failure at delivery, despite pMTCT or antiretroviral therapy (ART). METHODS: Samples from HIV-infected pregnant women from a rural area in southern Mozambique were analysed. Only women with HIV-1 RNA >400c/mL at delivery were included in the analysis. HIVDRM were determined using MiSeq® (detection threshold 1%) at the first antenatal care (ANC) visit and at the time of delivery. RESULTS: Ninety and 60 samples were available at the first ANC visit and delivery, respectively. At first ANC, 97% of the women had HIV-1 RNA>400c/mL, 39% had CD4+ counts <350 c/mm(3) and 30% were previously not on ART. Thirteen women (14%) had at least one HIVDRM of whom 70% were not on previous ART. Eight women (13%) had at least one HIVDRM at delivery. Out of 37 women with data available from the two time points, 8 (21%) developed at least one new HIVDRM during pMTCT or ART. Twenty seven per cent (53/191), 32% (44/138) and 100% (5/5) of the mutations that were present at enrolment, delivery and that emerged during pregnancy, respectively, were minority mutations (frequency <20%). CONCLUSIONS: Even with ultrasensitive HIV-1 genotyping, less than 20% of women with detectable viremia at delivery had HIVDRM before initiating pMTCT or ART. This suggests that factors other than pre-existing resistance, such as lack of adherence or interruptions of the ANC chain, are also relevant to explain lack of virological suppression at the time of delivery in women receiving antiretrovirals drugs during pregnancy. |
format | Online Article Text |
id | pubmed-5942837 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-59428372018-05-18 HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique Rupérez, María Noguera-Julian, Marc González, Raquel Maculuve, Sonia Bellido, Rocío Vala, Anifa Rodríguez, Cristina Sevene, Esperança Paredes, Roger Menéndez, Clara PLoS One Research Article BACKGROUND: Few data on HIV resistance in pregnancy are available from Mozambique, one of the countries with the highest HIV toll worldwide. Understanding the patterns of HIV drug resistance in pregnant women might help in tailoring optimal regimens for prevention of mother to child transmission of HIV (pMTCT) and antenatal care. OBJECTIVES: To describe the frequency and characteristics of HIV drug resistance mutations (HIVDRM) in pregnant women with virological failure at delivery, despite pMTCT or antiretroviral therapy (ART). METHODS: Samples from HIV-infected pregnant women from a rural area in southern Mozambique were analysed. Only women with HIV-1 RNA >400c/mL at delivery were included in the analysis. HIVDRM were determined using MiSeq® (detection threshold 1%) at the first antenatal care (ANC) visit and at the time of delivery. RESULTS: Ninety and 60 samples were available at the first ANC visit and delivery, respectively. At first ANC, 97% of the women had HIV-1 RNA>400c/mL, 39% had CD4+ counts <350 c/mm(3) and 30% were previously not on ART. Thirteen women (14%) had at least one HIVDRM of whom 70% were not on previous ART. Eight women (13%) had at least one HIVDRM at delivery. Out of 37 women with data available from the two time points, 8 (21%) developed at least one new HIVDRM during pMTCT or ART. Twenty seven per cent (53/191), 32% (44/138) and 100% (5/5) of the mutations that were present at enrolment, delivery and that emerged during pregnancy, respectively, were minority mutations (frequency <20%). CONCLUSIONS: Even with ultrasensitive HIV-1 genotyping, less than 20% of women with detectable viremia at delivery had HIVDRM before initiating pMTCT or ART. This suggests that factors other than pre-existing resistance, such as lack of adherence or interruptions of the ANC chain, are also relevant to explain lack of virological suppression at the time of delivery in women receiving antiretrovirals drugs during pregnancy. Public Library of Science 2018-05-09 /pmc/articles/PMC5942837/ /pubmed/29742132 http://dx.doi.org/10.1371/journal.pone.0196451 Text en © 2018 Rupérez et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Rupérez, María Noguera-Julian, Marc González, Raquel Maculuve, Sonia Bellido, Rocío Vala, Anifa Rodríguez, Cristina Sevene, Esperança Paredes, Roger Menéndez, Clara HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique |
title | HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique |
title_full | HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique |
title_fullStr | HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique |
title_full_unstemmed | HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique |
title_short | HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique |
title_sort | hiv drug resistance patterns in pregnant women using next generation sequence in mozambique |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942837/ https://www.ncbi.nlm.nih.gov/pubmed/29742132 http://dx.doi.org/10.1371/journal.pone.0196451 |
work_keys_str_mv | AT ruperezmaria hivdrugresistancepatternsinpregnantwomenusingnextgenerationsequenceinmozambique AT noguerajulianmarc hivdrugresistancepatternsinpregnantwomenusingnextgenerationsequenceinmozambique AT gonzalezraquel hivdrugresistancepatternsinpregnantwomenusingnextgenerationsequenceinmozambique AT maculuvesonia hivdrugresistancepatternsinpregnantwomenusingnextgenerationsequenceinmozambique AT bellidorocio hivdrugresistancepatternsinpregnantwomenusingnextgenerationsequenceinmozambique AT valaanifa hivdrugresistancepatternsinpregnantwomenusingnextgenerationsequenceinmozambique AT rodriguezcristina hivdrugresistancepatternsinpregnantwomenusingnextgenerationsequenceinmozambique AT seveneesperanca hivdrugresistancepatternsinpregnantwomenusingnextgenerationsequenceinmozambique AT paredesroger hivdrugresistancepatternsinpregnantwomenusingnextgenerationsequenceinmozambique AT menendezclara hivdrugresistancepatternsinpregnantwomenusingnextgenerationsequenceinmozambique |